BC
EVH icon

Bridgefront Capital’s Evolent Health EVH Stock Holding History

Bridgefront Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,644
Closed -$218K – 540
2024
Q1 		$218K Buy
+6,644
New +$212K 0.17% 293

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bridgefront Capital's EVH Position: Q2 2024 in Review

Bridgefront Capital sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 6,644 shares — an estimated $218K sold.

Bridgefront Capital first reported a position in EVH in Q1 2024 and held it in 1 quarter. The position peaked at $218K in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Bridgefront Capital reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Bridgefront Capital sold 6,644 Evolent Health shares in Q2 2024, an estimated $218K.
  • Bridgefront Capital first reported a position in Evolent Health in Q1 2024 and held it in 1 quarter.
  • Bridgefront Capital's Evolent Health position peaked at $218K in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.